#1 Clinical Trials Search in Europe

PHENTOLAMINE MESILATE

Phentolamine mesilate (also known as phentolamine mesylate) is a versatile medication that has found applications across various medical fields. Originally developed as a vasodilator, this non-selective alpha-adrenergic antagonist works by blocking both alpha-1 and alpha-2 adrenergic receptors, which leads to relaxation of blood vessels and improved blood flow. Recent clinical trials have explored its use in several innovative applications, from reversing dental anesthesia to treating night vision disturbances and addressing cardiovascular conditions. This article examines the current clinical research on phentolamine mesilate, highlighting its mechanisms of action, potential benefits, and safety considerations for patients.

Table of Contents

What is Phentolamine Mesilate?

Phentolamine mesilate (also known as phentolamine mesylate) is a medication that belongs to a class of drugs called alpha-adrenergic antagonists or alpha-blockers. It works by blocking the activity of certain receptors in the body called alpha-adrenergic receptors, which are responsible for the constriction of blood vessels. Phentolamine is a non-selective alpha-blocker, meaning it blocks both alpha-1 and alpha-2 receptors[1].

This medication has been in use since 1952 when it was initially approved for treating dermal necrosis and severe hypertension cases[2]. Over the years, researchers have discovered various applications for phentolamine mesilate in different areas of medicine, from dentistry to ophthalmology.

Mechanism of Action

Phentolamine mesilate works as a vasodilator, meaning it causes blood vessels to widen or dilate. It achieves this by blocking alpha-adrenergic receptors, which are typically activated by chemicals like norepinephrine that cause blood vessels to constrict[3].

When phentolamine blocks these receptors, it prevents the constriction of blood vessels, leading to increased blood flow to tissues. This vasodilatory effect is the basis for many of its therapeutic applications. By relaxing blood vessels, phentolamine can help redistribute substances away from injection sites, reduce blood pressure, or improve blood flow to specific tissues[4].

Medical Uses

Phentolamine mesilate has several medical applications based on its pharmacological properties. Let’s explore the major uses in different medical fields:

Dental Applications

Reversing Local Anesthesia

One of the most well-studied uses of phentolamine mesilate is in dentistry, where it’s marketed under the brand name OraVerse. This application was approved by the U.S. Food and Drug Administration (FDA) in May 2008 for patients over 6 years of age and weighing more than 15 kg. Later, in March 2016, the FDA approved its use in pediatric patients 3 years and older[2].

When you receive local anesthesia for a dental procedure, the numbing effect can last for several hours after your treatment is complete. This lingering numbness can be uncomfortable and may affect your ability to eat, speak, or return to normal activities. It can also increase the risk of self-inflicted soft tissue injuries, especially in children who might accidentally bite their numb lips or cheeks[2].

Phentolamine mesilate helps to reverse this numbing effect by counteracting the vasoconstrictor (like epinephrine) that is typically included in local anesthetics. The vasoconstrictor keeps the anesthetic in place longer, but phentolamine promotes the redistribution of the anesthetic away from the injection site, allowing for a faster return to normal sensation[4].

Clinical studies have shown that phentolamine mesilate can reduce the duration of soft tissue anesthesia by about 85 minutes in the upper and lower lips when compared to a placebo[2]. This means you can regain normal feeling in your mouth much sooner after dental procedures.

How It’s Used in Dentistry

For dental applications, phentolamine mesilate (OraVerse) is typically administered in a 1:1 ratio to the amount of local anesthetic that was used. For example, if your dentist used one cartridge of local anesthetic, they would use one cartridge of phentolamine mesilate. For children weighing less than 30 kg, only half of the cartridge is used, according to the manufacturer’s instructions[2].

The injection is given in the same site where the local anesthetic was administered, usually after the completion of the dental procedure. Studies have shown that phentolamine mesilate is effective at reversing the numbing effects of various dental anesthetics, including lidocaine, articaine, and bupivacaine[5].

Ophthalmic Applications

Reversing Pharmacologically-Induced Mydriasis

Phentolamine mesilate is also being studied for use in ophthalmology as an eye drop solution (known as Nyxol) to reverse pupil dilation (mydriasis) that occurs during eye examinations. When you visit an eye doctor, they often dilate your pupils using eye drops to better examine the inside of your eyes. This dilation can last for several hours, causing sensitivity to light and blurred vision, which can be inconvenient and sometimes dangerous, especially for driving[6].

Research shows that phentolamine ophthalmic solution can help expedite the reversal of this pharmacologically induced mydriasis. By blocking alpha-adrenergic receptors in the iris, phentolamine allows the pupil to return to its normal size more quickly[7].

Improving Night Vision

Another ophthalmic application being investigated is the use of phentolamine mesilate for improving night vision disturbances. Some people experience poor vision in low light conditions, which can affect their ability to drive at night or navigate in dimly lit environments[1].

Studies are examining whether phentolamine ophthalmic solution can improve mesopic (low light) contrast sensitivity and visual acuity. The medication may help by allowing more precise control of pupil size, which can optimize the amount of light entering the eye under different lighting conditions[8].

Treatment for Presbyopia

Phentolamine is also being studied as a potential treatment for presbyopia, which is the age-related loss of ability to focus on near objects. This condition typically begins to affect people around the age of 40 and is usually corrected with reading glasses or bifocals[9].

Researchers are investigating whether phentolamine ophthalmic solution can improve near vision in people with presbyopia by affecting pupil size and potentially other aspects of the visual system[9].

Cardiovascular Applications

Management of Hypertension

Phentolamine mesilate has been used in the management of hypertensive crises (severely high blood pressure). It produces vasodilation, which helps to lower blood pressure. However, this use has largely been replaced by newer medications with fewer side effects[10].

Prevention of Contrast-Associated Acute Kidney Injury

Recent research is exploring the use of phentolamine to prevent contrast-associated acute kidney injury (CA-AKI) in patients undergoing cardiac procedures like percutaneous coronary intervention (PCI). Contrast agents used during these procedures can sometimes cause kidney damage, and phentolamine’s vasodilatory properties may help protect the kidneys by improving blood flow[11].

Management of Severe Preeclampsia

Phentolamine is being studied for the management of severe preeclampsia, a condition that causes high blood pressure during pregnancy. Research is comparing the effects of phentolamine to other medications like labetalol on blood pressure and cerebral blood flow in pregnant women with this condition[12].

Other Uses

Treatment of Erectile Dysfunction

Phentolamine has been used as part of combination therapy for erectile dysfunction. It can be administered as an intracavernous injection (directly into the penis) along with other medications like papaverine and alprostadil (prostaglandin E1) to help improve blood flow to the penis and achieve an erection[13].

Hypotensive Anesthesia

Phentolamine may be used to achieve controlled hypotension (deliberately lowered blood pressure) during certain surgical procedures, such as functional endoscopic sinus surgery. Lowering blood pressure in a controlled manner can reduce bleeding during surgery, improving visibility for the surgeon[10].

Research on Insulin Resistance and Glucose Metabolism

Some research studies are investigating the effects of phentolamine on insulin-mediated glucose uptake and metabolism. These studies aim to understand how blocking alpha-adrenergic receptors might affect glucose handling in conditions like insulin resistance and heart failure[14].

Dosage and Administration

The dosage and administration of phentolamine mesilate vary depending on its application:

For Dental Use (OraVerse)

  • For adults and children weighing 30 kg or more: The dose is equal to the amount of local anesthetic that was used (typically one cartridge, or 1.7 mL containing 0.4 mg of phentolamine)
  • For children weighing less than 30 kg: Half the amount of a cartridge is used
  • The injection is given in the same site as the local anesthetic

For Ophthalmic Use (Nyxol)

  • For reversing mydriasis: One or two drops in each eye, with concentrations typically between 0.75% and 1%
  • For night vision disturbances: One drop in each eye at bedtime (8-10 PM), with ongoing daily administration for up to 14 days or more depending on the study protocol

For Cardiovascular Applications

  • For hypertensive emergencies: The dosage is typically individualized based on the patient’s response, but may start with a loading dose of 1-5 mg IV bolus followed by an infusion rate of 0.1-2 mg/min
  • For prevention of contrast-associated kidney injury: Dosing protocols are still being established in research studies

It’s important to note that phentolamine mesilate should only be administered by healthcare professionals who are trained in its use and can monitor for potential side effects[2].

Side Effects

Like all medications, phentolamine mesilate can cause side effects. The frequency and severity of these effects often depend on the dose, route of administration, and individual patient factors[3].

Common Side Effects

  • Hypotension (low blood pressure)
  • Reflex tachycardia (increased heart rate)
  • Dizziness or lightheadedness
  • Flushing (reddening of the skin)
  • Nasal congestion

For Dental Applications (OraVerse)

  • Pain at the injection site
  • Headache
  • Temporary increase in blood pressure or heart rate

For Ophthalmic Applications (Nyxol)

  • Conjunctival hyperemia (redness of the eye)
  • Eye irritation or discomfort
  • Temporary changes in vision

Less Common but Serious Side Effects

  • Severe hypotension
  • Arrhythmias (irregular heartbeats)
  • Myocardial infarction (heart attack) – rare
  • Cerebrovascular accidents (stroke) – rare

If you experience any concerning symptoms after receiving phentolamine mesilate, it’s important to seek medical attention promptly[12].

Contraindications

Phentolamine mesilate should not be used in certain situations. These contraindications include:

  • Known hypersensitivity or allergy to phentolamine or any components of the formulation
  • Severe heart disease or recent myocardial infarction
  • Unstable angina
  • Uncontrolled cardiac arrhythmias
  • Severe hypotension

For ophthalmic applications, additional contraindications may include certain eye conditions or previous adverse reactions to eye medications[15].

It’s essential to provide your healthcare provider with a complete medical history, including information about any heart conditions, blood pressure issues, or other medications you’re taking, before receiving phentolamine mesilate[3].

Conclusion

Phentolamine mesilate is a versatile medication with applications across multiple medical fields. From reversing dental anesthesia to improving night vision and managing cardiovascular conditions, this alpha-adrenergic blocker offers several therapeutic benefits based on its vasodilatory properties.

As research continues, we may see further developments and expanded applications for phentolamine mesilate in the future. If you’re considering a treatment that involves this medication, discuss the potential benefits and risks with your healthcare provider to determine if it’s appropriate for your specific situation[16].

Application Formulation Mechanism of Action Key Benefits Patient Population Status
Dental Anesthesia Reversal OraVerse – injectable solution (0.4mg/1.7ml) Reverses vasoconstriction caused by epinephrine in dental anesthetics, accelerating anesthetic clearance Reduces time to normal sensation by up to 85 minutes; decreases risk of self-inflicted soft tissue trauma Children ≥3 years and adults; particularly beneficial for children at risk of lip/tongue biting FDA approved since 2008; initially for patients ≥6 years, expanded to ≥3 years in 2016
Reversal of Pharmacologic Mydriasis Nyxol – ophthalmic solution 0.75% Blocks alpha-adrenergic receptors in iris dilator muscle, allowing pupil constriction Accelerates return to normal pupil size after eye exams; reduces time of blurry vision and light sensitivity Adults and pediatric patients who need eye dilation for exams but want faster recovery In Phase 3 clinical trials (MIRA-2, MIRA-3, MIRA-4 studies)
Night Vision Disturbances Nyxol – ophthalmic solution 0.75-1.0% Moderately reduces pupil size to optimize light entry and reduce aberrations Improves mesopic contrast sensitivity and low contrast visual acuity; helps with night driving Patients with dim light vision complaints, especially after refractive surgery In Phase 3 clinical trials (LYNX-1 study)
Glaucoma/Ocular Hypertension Nyxol – ophthalmic solution 1.0% May lower intraocular pressure through vasodilation of ocular blood vessels Potential new treatment option with different mechanism than existing glaucoma medications Patients with open-angle glaucoma or ocular hypertension In Phase 2 clinical trials (ORION-1 study)
Cardiovascular Applications Injectable solution (various concentrations) Dilates blood vessels, reducing peripheral vascular resistance Management of hypertensive emergencies; protection against contrast-induced kidney injury; research applications in insulin sensitivity Patients with hypertensive emergencies; those at risk for contrast-associated acute kidney injury Various stages of research and clinical use

FAQ

  • What is phentolamine mesilate and how does it work? Phentolamine mesilate is a non-selective alpha-adrenergic blocking agent that works by blocking both alpha-1 and alpha-2 adrenergic receptors. This blocking action causes blood vessels to dilate (widen), which increases blood flow. In dental applications (as OraVerse), it helps reverse the effects of local anesthetics by counteracting the vasoconstrictor (like epinephrine) that was combined with the anesthetic. In ophthalmic applications (as Nyxol), it affects pupil size and potentially improves vision under certain conditions by acting on the muscles that control the iris.
  • How is phentolamine mesilate used in dentistry? In dentistry, phentolamine mesilate (brand name OraVerse) is used to reverse the numbing effects of local anesthesia. After dental procedures, the lingering numbness from anesthetics like lidocaine or bupivacaine can last for 3-5 hours, causing discomfort and sometimes leading to self-injury from accidental biting of the lips or tongue. When injected at the same site as the original anesthetic, phentolamine helps speed up the return of normal sensation by dilating blood vessels, which accelerates the removal of the anesthetic from the injection site. Clinical trials have shown it can reduce recovery time by up to 85 minutes.
  • What are the potential benefits of phentolamine mesilate for vision problems? Clinical trials are investigating phentolamine mesilate as an ophthalmic solution (Nyxol) for several vision-related issues. It's being studied for: (1) improving night vision disturbances by enhancing contrast sensitivity in low light conditions, (2) reversing pharmacologically-induced pupil dilation (mydriasis) after eye exams, potentially reducing recovery time from hours to minutes, (3) treating presbyopia (age-related farsightedness), and (4) potentially helping patients with glaucoma by lowering intraocular pressure. The medication works by affecting the muscles that control pupil size.
  • Are there any side effects associated with phentolamine mesilate? Like all medications, phentolamine mesilate can cause side effects, though they vary depending on the application method and dosage. In dental applications, potential side effects may include post-operative pain, increased bleeding at the injection site, headache, and changes in heart rate or blood pressure. For ophthalmic applications, the most common side effect is conjunctival hyperemia (eye redness). In some clinical trials, researchers are even evaluating medications like Lumify to reduce this redness. Systemic effects can include changes in blood pressure and heart rate, especially when used in higher doses for cardiovascular applications. It's important to discuss potential risks with your healthcare provider.
  • Who might benefit most from phentolamine mesilate treatments? Different patient groups may benefit from phentolamine mesilate depending on the application. In dentistry, children and patients with anxiety about prolonged numbness might benefit most from OraVerse. Dental patients undergoing longer procedures with longer-lasting anesthetics like bupivacaine might also find it helpful. In ophthalmology, patients with night vision disturbances, particularly after refractive surgery, might benefit from Nyxol eye drops. People who need eye examinations but can't afford prolonged pupil dilation (like professionals who need to return to work) might benefit from its mydriasis-reversing properties. For cardiovascular applications, certain patients with hypertensive emergencies or specific diagnostic needs might benefit from its vasodilating properties.

Ongoing Clinical Trials on PHENTOLAMINE MESILATE

  • Study on Sildenafil and Vacuum Erection Device Therapy for Men with Prostate Cancer Undergoing Nerve-Sparing Surgery

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Alpha-adrenergic antagonist: A medication that blocks alpha-adrenergic receptors, which are proteins on cell surfaces that respond to stress hormones like adrenaline (epinephrine) and noradrenaline (norepinephrine). By blocking these receptors, phentolamine causes blood vessels to relax and widen, increasing blood flow.
  • Contrast sensitivity: The ability to distinguish between an object and its background based on differences in light and dark. This is a crucial aspect of vision, particularly in low-light conditions, and is measured during vision tests using special charts with varying levels of contrast.
  • Cycloplegic agents: Medications that temporarily paralyze the ciliary muscles of the eye, preventing accommodation (focusing). These are often used during eye examinations and include drugs like tropicamide and cyclopentolate.
  • ETDRS letters: Early Treatment Diabetic Retinopathy Study letters, which are standardized vision testing charts used to measure visual acuity. An improvement of 15 ETDRS letters is equivalent to 3 lines on an eye chart, which is considered clinically significant.
  • HACSS methodology: A testing methodology used to measure contrast sensitivity at different spatial frequencies. This helps evaluate how well a person can see objects of different sizes and contrast levels.
  • Hyperinsulinemic euglycemic clamp: A technique used to measure insulin sensitivity by maintaining a constant blood glucose level while infusing insulin. This technique is used in research to study how drugs affect glucose metabolism.
  • Inferior alveolar nerve block: A type of dental anesthesia that numbs the lower teeth, lower lip, chin, and tongue on one side by injecting anesthetic near the nerve that supplies these areas.
  • Local anesthesia: Medication that blocks pain in a specific area of the body by temporarily preventing nerve signals from transmitting pain sensations to the brain. In dentistry, it's used to numb areas of the mouth during procedures.
  • Mesopic conditions: Lighting conditions between bright light (photopic) and very low light (scotopic), such as twilight or indoor lighting. These conditions are particularly challenging for people with certain vision problems.
  • Mydriasis: Dilation of the pupil, which can occur naturally or be induced medically using mydriatic agents for eye examinations. Prolonged mydriasis can cause light sensitivity and blurred vision, particularly for near objects.
  • mLCVA: Mesopic Low Contrast Visual Acuity, which measures how well a person can see low-contrast objects under medium-light conditions. This is particularly important for night driving and other low-light activities.
  • Night vision disturbances: Visual problems that occur specifically in low-light conditions, such as difficulty seeing in dim light, halos around lights, glare sensitivity, and reduced contrast sensitivity. These can occur naturally or as a side effect of eye surgery.
  • Ocular hypertension: Elevated pressure within the eye (intraocular pressure) that is higher than normal but has not yet caused optic nerve damage or visual field loss characteristic of glaucoma. It is a risk factor for developing glaucoma.
  • Open angle glaucoma: A common form of glaucoma where the drainage angle for fluid within the eye remains open, but the fluid drains too slowly, causing increased intraocular pressure which can damage the optic nerve.
  • OraVerse: The brand name for phentolamine mesylate when used in dentistry to reverse the effects of local anesthesia. It was approved by the FDA in 2008 for patients over 6 years of age and weighing more than 15 kg.
  • Phentolamine mesylate: A non-selective alpha-adrenergic antagonist medication that blocks both alpha-1 and alpha-2 receptors, causing blood vessels to dilate. It's used in various medical applications including reversing dental anesthesia and treating certain eye conditions.
  • Presbyopia: An age-related condition where the eye gradually loses the ability to focus on close objects due to hardening of the lens. It typically becomes noticeable in one's mid-40s and continues to progress until about age 65.
  • Pupil diameter: The measurement of the size of the pupil, the black center of the eye. Pupil size changes in response to light levels, emotional states, and certain medications. It's measured in millimeters and is important in various eye examinations.
  • Nyxol: The brand name for phentolamine mesylate when formulated as an ophthalmic solution for eye-related applications, such as treating night vision disturbances or reversing pharmacologically-induced mydriasis.
  • Tachyphylaxis: A medical term describing the rapid decrease in response to a drug after repeated administration, making the drug less effective. This can occur with local anesthetics, requiring higher doses to maintain the same effect.
  • Vasoconstrictor: A substance that narrows blood vessels, reducing blood flow. In dental anesthetics, vasoconstrictors like epinephrine are added to prolong the numbing effect by keeping the anesthetic localized to the injection area.
  • Vasodilator: A substance that widens blood vessels, increasing blood flow. Phentolamine acts as a vasodilator by blocking the receptors that cause blood vessel constriction.

References

  1. https://clinicaltrials.gov/study/NCT01703559
  2. https://clinicaltrials.gov/study/NCT05448807
  3. https://clinicaltrials.gov/study/NCT03098680
  4. https://clinicaltrials.gov/study/NCT02861378
  5. https://clinicaltrials.gov/study/NCT02995291
  6. https://clinicaltrials.gov/study/NCT04024891
  7. https://clinicaltrials.gov/study/NCT04620213
  8. https://clinicaltrials.gov/study/NCT04004507
  9. https://clinicaltrials.gov/study/NCT06542497
  10. https://clinicaltrials.gov/study/NCT06620991
  11. https://clinicaltrials.gov/study/NCT06286059
  12. https://clinicaltrials.gov/study/NCT06385600
  13. https://clinicaltrials.gov/study/NCT00080808
  14. https://clinicaltrials.gov/study/NCT00132106
  15. https://clinicaltrials.gov/study/NCT05223478
  16. https://clinicaltrials.gov/study/NCT07140783